跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 78 条关于
“nipocalimab-aahu”
全部
78
临床试验
27
药物
4
机构
1
资讯
46
17天前
FDA Approves Johnson & Johnson's IMAAVY (nipocalimab-aahu) as First Therapy for Warm Autoimmune Hemolytic Anemia
10个月前
Nipocalimab Demonstrates Significant Efficacy in Phase 2 Sjögren's Disease Trial Published in The Lancet
6个月前
Johnson & Johnson Seeks FDA Approval for First-Ever Treatment of Rare Blood Disorder wAIHA
去年
FDA Approves Nipocalimab for Myasthenia Gravis as Pipeline Advances with 20+ Novel Therapies
10个月前
Johnson & Johnson Launches First Head-to-Head FcRn Blocker Study in Myasthenia Gravis
去年
Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease
去年
Nipocalimab Receives Second FDA Breakthrough Therapy Designation for Sjögren's Disease
2年前
J&J's Nipocalimab Shows Promise in Treating Autoimmune Diseases
去年
Nipocalimab Granted FDA Breakthrough Therapy Designation for Sjögren's Disease
去年
Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease
第 1 页,共 5 页
上一页
下一页